Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag crawled date : 2022 - 09 - 28 save search
Calidi Biotherapeutics Appoints David Sans, FAARM, Ph.D., MBA, as Head of Corporate Development
Published: 2022-09-28 (Crawled : 22:00) - biospace.com/
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: 1.32%
H: 0.31%
C: -0.54%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 1.46%
H: 1.25%
C: 0.77%
Global Glaucoma Treatment Market to Grow at 5.2% Annually Through 2027
Published: 2022-09-28 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 0.22%
H: 0.33%
C: 0.33%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 1.87%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -0.05%
H: 0.47%
C: -0.56%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.17%
H: 1.1%
C: 0.16%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -0.05%
H: 0.41%
C: -1.17%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
REGN | News | $906.54 -0.09% -0.08% 280K
|
Health Technology
|
| O: -0.08%
H: 0.25%
C: -1.85%
AERI | $15.25 0.0%
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: -0.13%
treatment glaucoma global market
Global Biosimilars Market to Reach $88.12 Billion by 2030
Published: 2022-09-28 (Crawled : 19:00) - prnewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 1.87%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.17%
H: 1.1%
C: 0.16%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: -1.36%
global market
Alzheimer's Disease Therapeutics Market to record USD 3.99 Bn growth -- Driven by the availability, research, and development of novel biomarkers
Published: 2022-09-28 (Crawled : 09:00) - prnewswire.com
GIKLY | $4.4 -3.93% 132.75% 76
|
Manufacturing
|
| O: -6.72%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 4.4M
|
Health Technology
|
| O: 0.94%
H: 2.22%
C: 1.99%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 1.46%
H: 1.25%
C: 0.77%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 1.76%
H: 0.76%
C: 0.26%
DNLI | $15.56 -3.41% -3.6% 40
|
Health Technology
|
| O: 6.45%
H: 16.46%
C: 10.57%
BIIB | $201.99 4.56% 4.32% 420
|
Health Technology
|
| O: 43.06%
H: 0.17%
C: -2.24%
disease alzheimer's therapeutics biomarkers growth market
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 17M
|
TSLA | News | $162.13 12.06% 10.13% 170M
|
Consumer Durables
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.